Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.
Choose from the criteria below to find an activity that fits you best.
NOTE: If you attended the live CE activity that was held on December 5, 2018 AND received CE credit (i.e. a pharmacist or Pharmacy Technician CE statement of credit with ACPE UAN 0221-9999-18-376-L05-P/T), you are NOT allowed to also receive credit for this home-study on-demand web activity.
While much emphasis has been placed on the improvement of IV infusion safety, there remains limited published information on safe practices associated with IV push injection safety. Recent ISMP insight has revealed significant risk associated with the preparation and administration of IV push medications. At this symposium, experts will address the variability of practice with IV push medication use, including unnecessary unit-based preparation and dilution and unsafe injection practices, highlighting strategies necessary for the mitigation of risk. A new gap analysis tool will be presented that can be used by organizations to align best practices.
Upon completion of this activity, participants will be able to:
Introduction and Overview
Michael R. Cohen, RPh, MS, ScD (hon.), DPS (hon.), FASHP
Understanding the Challenges and Risk Associated with IV Push Medication Use
Michelle Mandrack, MSN, RN
Director of Consulting Services, ISMP
ISMP Guidelines for Safe Practices: An Interdisciplinary Best Practice Approach
Susan Paparella, MSN, RN
Vice President, ISMP
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Mr. Cohen, Ms. Paparella, and Ms. Mandrack have no relevant commercial or financial relationships to disclose.
Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
Release Date: 2-15-2019
Expiration Date: 2-15-2022
This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-19-054-H05-P/T has been assigned to this knowledge-based home-study CE activity (initial release date 2-15-19). This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
This CE activity is jointly provided by the Institute for Safe Medication
Practices (ISMP), ProCE, Inc., and Wild Iris Medical Education, Inc. This activity
provides 1.5 contact hour of nurse CE credit.
Wild Iris Medical Education, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This CE activity is supported by an educational grant from Baxter.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.